SOBR
SOBR Safe, Inc.1.4400
-0.0599-3.99%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
2.18MP/E (TTM)
0.00Basic EPS (TTM)
333.79Dividend Yield
0%Recent Filings
8-K
CEO/CFO terms extended
SOBR Safe amended employment agreements for CEO David J. Gandini and CFO Christopher Whitaker on December 30, 2025, extending both terms to December 31, 2026. Leadership locked in. Effective December 26, 2025, the company switched transfer agent from Equiniti to Broadridge, shifting all directly held common shares to its platform.
8-K
SOBR closes $2M placement
SOBR Safe closed a $2M private placement on December 29, 2025, issuing 370,000 shares and pre-funded warrants for 920,324 shares at $1.55 each, plus Series C/D warrants for 1,290,324 shares at $1.30 exercisable immediately (5-year/24-month terms). H.C. Wainwright acted as agent; proceeds fund working capital. Cash locked in; warrants add overhang.
8-K
Q3 revenue surges 136%
SOBRsafe reported Q3 2025 revenue of $108.9 thousand, up 136.1% year-over-year, driven by 277 SOBRsure GEN 2 device sales contributing 80.7% of total. Gross margin dipped to 34.8% from strategic pricing, while operating expenses rose to $2.3 million amid marketing push; cash fell to $4.7 million. October hit record sales. Marketing sharpened sales cycles.
10-Q
Q3 FY2025 results
SOBR Safe posted Q3 revenue of $108.9k, up 136% y/y and (derived) 55% q/q from SOBRsure device and subscription sales, yet gross margin slipped to 34.8% from 65.3% y/y due to pricing cuts and product replacements now fixed. Operating loss widened to $2.2M from $1.8M y/y on higher G&A from marketing and payroll, while R&D dropped 85%. Cash fell to $4.7M after $5.3M op cash burn, offset by $3.7M warrant exercises less $1.6M PIPE true-up; total debt stays low at $222k, all current. Warrants burned nicely. Supply chain disruptions from sub-suppliers pose risks.
8-K
European patent and Q2 revenue surge
SOBR Safe bolstered its IP fortress with a European Patent for the SOBRcheck device, covering noninvasive transdermal alcohol detection tech, paving the way for pilots in Europe starting late 2025. Q2 revenue surged 92.3% year-over-year to $104.2 thousand, driven by 178 SOBRsure GEN 2 device shipments and software subscriptions, lifting gross margins to 57.5% while net loss narrowed to $2.0 million. Cash holds steady at $8.5 million. Patent secures global edge, yet commercialization ramps slowly.
IPO
Website
Employees
Sector
Industry
ASTC
Astrotech Corporation
3.92+0.44
CLBT
Cellebrite DI Ltd.
18.23+0.38
GWSO
Global Warming Solutions, Inc.
0.37-0.02
LCTC
Lifeloc Technologies, Inc.
2.60+0.00
SOTK
Sono-Tek Corporation
3.70+0.10
SSGC
SafeSpace Global Corporation
0.30+0.03
SSTI
SoundThinking, Inc.
7.93+0.23
SVRE
SaverOne 2014 Ltd.
1.88-1.66
WRAP
Wrap Technologies, Inc.
2.19-0.15
XTRAF
XTRACT ONE TECHNOLOGIES INC.
0.46-0.02